Li, Qiyu

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2015 | 2013

2015

Gautschi, O.; Mach, N.; Rothschild, S.; Li, Qiyu; Stahel, R. A.; Zippelius, A.; Cathomas, R.; Früh, M.; Betticher, D. C.; Peters, S.; Rauch, D.; Feilchenfeldt, J.; Bubendorf, L.; Savic, S.; Jaggi, Rolf; Oppliger Leibundgut, Elisabeth; Largiadèr, Carlo Rodolfo; Brutsche, M.; Pilop, C.; Stalder, L.; ... (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical lung cancer, 16(5), pp. 358-365. Elsevier 10.1016/j.cllc.2015.02.007

Käser, S. A.; Froelicher, J.; Li, Qiyu; Müller, S.; Metzger, U.; Castiglione, M.; Laffer, U. T.; Maurer, C. A. (2015). Adenocarcinomas of the upper third of the rectum and the rectosigmoid junction seem to have similar prognosis as colon cancers even without radiotherapy, SAKK 40/78. Langenbeck's archives of surgery, 400(6), pp. 675-682. Springer 10.1007/s00423-014-1243-1

Varga, Z.; Cassoly, E.; Li, Qiyu; Oehlschlegel, C.; Tapia, C.; Lehr, H. A.; Klingbiel, D.; Thuerlimann, B.; Ruhstaller, T. (2015). Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study. PLoS ONE, 10(4), e0123435. Public Library of Science 10.1371/journal.pone.0123435

2013

Hitz, F.; Ribi, K.; Li, Qiyu; Klingbiel, Dirk; Cerny, T.; Koeberle, D. (2013). Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer. Supportive care in cancer, 21(11), pp. 3085-3093. Springer 10.1007/s00520-013-1886-4

Passweg, Jakob R.; Pabst, Thomas; Blum, Sabine; Bargetzi, Mario; Li, Qiyu; Heim, Dominik; Stussi, Georg; Gregor, Michael; Leoncini, Leda; Meyer-Monard, Sandrine; Brauchli, Peter; Chalandon, Yves; Swiss Group for Clinical Cancer Research, SAKK (2013). Azacytidine for acute myeloid leukemia in elderly or frail patients: A phase II trial (SAKK 30/07). Leukemia & lymphoma, 55(1), pp. 87-91. London: Informa Healthcare 10.3109/10428194.2013.790540

Provide Feedback